The Internal Revenue Service notified the pharmaceutical giant in 2017 that it owed $3.6 billion in back taxes for the years 2010 to 2012 and demanded $5.1 billion more for the years 2013 to 2015 in 2020, according to the proposed class-action lawsuit filed Monday in Manhattan federal court.
Under federal rules, publicly traded companies are required to disclose adverse financial situations to investors. ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.